Clin2
NCT06896370Likely a fitRecruiting

Gastric cancer study for people with high-risk H. pylori

Gastric (Stomach) CancerHelicobacter Infection

Part of Cancer, Digestive system, Infections clinical trials.

This study follows people who carry a high-risk type of Helicobacter pylori (a stomach bacteria) to see if they develop gastric cancer. It aims to understand who is most at risk and how to monitor them over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
40 years and older
Study type
Observational

Who can take part

  • You must be 40 years or older.
  • You must carry a high-risk type of H. pylori bacteria in your stomach.
  • You must agree to come back for regular check-ups over several years.
  • You cannot have had stomach cancer or other digestive tract cancers before.
  • You must be free of serious illnesses like severe heart, lung, liver, or kidney problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06943794Not yet recruiting
Testing treatment for high-risk H. pylori to prevent stomach cancer

This trial tests whether treating certain high-risk types of H. pylori (a stomach bacteria) can prevent stomach cancer. If you are 40 or older and have a high-risk H. pylori strain, you may be able to join.

Tongling
NCT07770126Recruiting
Stomach bacteria study for gastric conditions and precancer

This study looks for certain stomach bacteria (other than the common H. pylori) that might be linked to stomach diseases or early signs of cancer. If you have a stomach condition, your participation could help doctors understand these bacteria better.

Edegem
NCT06943781Recruiting
Gastric cancer screening using high-risk gene detection

This trial is testing a new way to identify people at higher risk for stomach cancer using a gene test for Helicobacter pylori. It may help detect cancer early in people aged 40 and older.

Tongling
NCT02047994Recruiting· Phase 4
Testing and treatment for H. pylori to prevent stomach cancer death

This trial studies whether testing for an infection called H. pylori and using simple blood/screening tests (pepsinogen testing) can help prevent stomach cancer and reduce stomach-cancer-related deaths. You would be followed for health outcomes to see if the approach works better than standard care.

Riga
NCT06853509Not yet recruiting
Predicting stomach cancer risk in people with high-risk features

This study uses endoscopy findings to predict if high-risk patients will develop stomach cancer or precancerous changes. It aims to improve follow-up care for people with signs of infection or stomach lining thinning.

Shanghai, Shanghai Municipality
NCT07724496Recruiting
H. pylori and stomach growth features study

This study looks at whether having H. pylori infection (a common stomach bacteria) and certain features of stomach growth can predict how early stomach cancer or pre-cancerous changes will behave and what your long-term outlook might be. You may be eligible if you are being treated with a camera-based removal procedure called endoscopic submucosal dissection (ESD).

Beijing, Beijing Municipality

Hear when a new Gastric (Stomach) Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.